Gemfibrozil significantly lowers cynomolgus monkey plasma lipoprotein[a]-protein and liver apolipoprotein[a] mRNA levels.
Eight male cynomolgus monkeys (Macaca fascicularis) on a normal chow diet were orally administered gemfibrozil daily using a weekly rising dose protocol for 3 weeks (50, 125, and 200 mg/kg per day). At these drug doses, Lp[a] levels were reduced: 83.7% +/- 3.2 (SEM), (P < 0.024); 63.7% +/- 4.1 (P...
Main Authors: | R. Ramharack, M.A. Spahr, G.W. Hicks, K.A. Kieft, D.W. Brammer, L.L. Minton, R.S. Newton |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1995-06-01
|
Series: | Journal of Lipid Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S002222752041137X |
Similar Items
-
Expression of apolipoprotein[a] and plasminogen mRNAs in cynomolgus monkey liver and extrahepatic tissues
by: R Ramharack, et al.
Published: (1996-09-01) -
Accelerated cholesteryl ester transfer and altered lipoprotein composition in diabetic cynomolgus monkeys.
by: J D Bagdade, et al.
Published: (1995-04-01) -
Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed rats.
by: B R Krause, et al.
Published: (1985-08-01) -
Role of liver in the synthesis of cholesterol and the clearance of low density lipoproteins in the cynomolgus monkey
by: S D Turley, et al.
Published: (1995-01-01) -
Effect of gemfibrozil on levels of lipoprotein[a] in type II hyperlipoproteinemic subjects.
by: P H Jones, et al.
Published: (1996-01-01)